Certain other clinical manifestations, including subependymal giant cell astrocytoma (SEGA), renal angiomyolipomas and cardiac rhabdomyomas, are more common in patients with TSC2 variants14–16. This evidence concerns the gene TSC2 and cardiac rhabdomyoma.